Medicare is now covering some GLP-1 weight loss drugs for $50. Here’s what to know

The federal government has introduced a program to make GLP-1 weight loss drugs more accessible and affordable for Medicare recipients, now covering them for just $50. This move is significant as it aims to help older Americans manage obesity-related health issues, potentially reducing the long-term burden on the healthcare system. The decision highlights the government's commitment to addressing chronic conditions through innovative treatments, which could lead to better health outcomes and lower overall medical costs in the future.